Jill Marie Broadfoot - Jun 4, 2025 Form 3 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Director
Signature
/s/ Jill Marie Broadfoot by Colin Sandercock, attorney-in-fact
Stock symbol
CUE
Transactions as of
Jun 4, 2025
Transactions value $
$0
Form type
3
Date filed
6/6/2025, 04:00 PM
Previous filing
Feb 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Broadfoot Jill Marie Director C/O CUE BIOPHARMA, INC., 40 GUEST STREET, BOSTON /s/ Jill Marie Broadfoot by Colin Sandercock, attorney-in-fact 2025-06-06 0001305178

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney